KKR & Co. is in final negotiations to acquire medical device manufacturer Integer Holdings. The proposed deal values Integer at approximately $127 per share. The total transaction value exceeds $4 billion. An official announcement could occur as early as next week.
The take-private transaction follows a strategic review initiated in April. Activist investor Irenic Capital Management prompted the review through sustained pressure. Integer shares surged over 20% following reports of KKR’s interest.
The acquisition strengthens KKR’s position within the medical technology industry. This sector remains a primary target for significant private equity investment.